Recombinant multi-species GDF1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GDF1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. Studies in rodents suggest that this protein is involved in the establishment of left-right asymmetry in early embryogenesis and in neural development in later embryogenesis. The encoded protein is translated from a bicistronic mRNA that also encodes ceramide synthase 1. Mutations in this gene are associated with several congenital cardiovascular malformations. [provided by RefSeq, Jul 2016]
The Alternative Names of target: CERS1,CHTD6,DORV,DTGA3,Embryonic growth/differentiation factor 1,GDF-1,GDF1,Gdf-1,Gdf1,LAG1,LASS1,RAI,UOG1

Target products collectionGo to GDF1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0938-Ag-1/ GM-Tg-hg-SE0938-Ag-2 Human GDF1 protein Human
GM-Tg-rg-SE0938-Ag-1/ GM-Tg-rg-SE0938-Ag-2 Rat GDF1 protein Rat
GM-Tg-mg-SE0938-Ag-1/ GM-Tg-mg-SE0938-Ag-2 Mouse GDF1 protein Mouse
GM-Tg-cynog-SE0938-Ag-1/ GM-Tg-cynog-SE0938-Ag-2 Cynomolgus/Rhesus macaque GDF1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0938-Ag-1/ GM-Tg-felg-SE0938-Ag-2 Feline GDF1 protein Feline
GM-Tg-cang-SE0938-Ag-1/ GM-Tg-cang-SE0938-Ag-2 Canine GDF1 protein Canine
GM-Tg-bovg-SE0938-Ag-1/ GM-Tg-bovg-SE0938-Ag-2 Bovine GDF1 protein Bovine
GM-Tg-equg-SE0938-Ag-1/ GM-Tg-equg-SE0938-Ag-2 Equine GDF1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0938-Ag-1/ GM-Tg-hg-SE0938-Ag-2; GM-Tg-rg-SE0938-Ag-1/ GM-Tg-rg-SE0938-Ag-2;
GM-Tg-mg-SE0938-Ag-1/ GM-Tg-mg-SE0938-Ag-2; GM-Tg-cynog-SE0938-Ag-1/ GM-Tg-cynog-SE0938-Ag-2;
GM-Tg-felg-SE0938-Ag-1/ GM-Tg-felg-SE0938-Ag-2; GM-Tg-cang-SE0938-Ag-1/ GM-Tg-cang-SE0938-Ag-2;
GM-Tg-bovg-SE0938-Ag-1/ GM-Tg-bovg-SE0938-Ag-2; GM-Tg-equg-SE0938-Ag-1/ GM-Tg-equg-SE0938-Ag-2
Products Name GDF1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name GDF1
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GDF1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.